We are live on
!
Find out more
Rafferty Asset Management Portfolio holdings
AUM
$24.6B
1-Year Est. Return
47.06%
This Fund
S&P 500
This Quarter
Est. Return
+13.66%
1 Year Est. Return
+47.06%
3 Year Est. Return
+108.18%
5 Year Est. Return
+135.84%
10 Year Est. Return
+427.13%
AUM
$14.8B
AUM Growth
+$2.81B
(+24%)
Cap. Flow
+$1.65B
Cap. Flow
% of AUM
11.18%
Top 10 Holdings %
Top 10 Hldgs %
32.19%
Holding
1,185
New
65
Increased
729
Reduced
346
Closed
45
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$323M |
| 2 |
iShares China Large-Cap ETF
FXI
|
+$107M |
| 3 |
Texas Instruments
TXN
|
+$85.9M |
| 4 |
Tesla
TSLA
|
+$67.3M |
| 5 |
Intel
INTC
|
+$65.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$45M |
| 2 |
NVIDIA
NVDA
|
+$36.4M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$26.7M |
| 4 |
Madrigal Pharmaceuticals
MDGL
|
+$21.1M |
| 5 |
JPMorgan Chase
JPM
|
+$19.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 42.08% |
| 2 | Financials | 11.46% |
| 3 | Healthcare | 8.37% |
| 4 | Energy | 5.47% |
| 5 | Consumer Discretionary | 4.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
376
Scilex Holding
SCLX
$46.1M
| $5.23M | 0.04% |
+18,216
| New | +$5.05M |
|
|
AXON
377
Axon Enterprise
AXON
$46.4B
| $5.14M | 0.03% |
22,849
-4,919
| -18% | -$978K |
|
378
Rocket Pharmaceuticals
RCKT
$372M
| $5.13M | 0.03% |
299,459
+5,498
| +2% | +$108K |
|
|
CERE
379
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
| $5.13M | 0.03% |
210,185
-28,470
| -12% | -$836K |
|
380
Immunovant
IMVT
$7.91B
| $5.09M | 0.03% |
327,916
+97,343
| +42% | +$1.69M |
|
381
Target
TGT
$67.8B
| $5.08M | 0.03% |
30,692
+196
| +0.6% | +$32.2K |
|
382
Public Storage
PSA
$60.9B
| $5.02M | 0.03% |
16,616
+2,211
| +15% | +$650K |
|
383
HCA Healthcare
HCA
$88B
| $5M | 0.03% |
18,973
+770
| +4% | +$196K |
|
384
Targa Resources
TRGP
$56.8B
| $4.97M | 0.03% |
68,129
-9,519
| -12% | -$702K |
|
385
MarketAxess Holdings
MKTX
$5.71B
| $4.96M | 0.03% |
12,685
-1,853
| -13% | -$656K |
|
386
Editas Medicine
EDIT
$407M
| $4.96M | 0.03% |
684,352
-86,600
| -11% | -$770K |
|
387
Arcturus Therapeutics
ARCT
$171M
| $4.95M | 0.03% |
206,474
-2,780
| -1% | -$49.9K |
|
388
Krystal Biotech
KRYS
$9.21B
| $4.93M | 0.03% |
61,524
-101
| -0.2% | -$7.93K |
|
389
Biohaven
BHVN
$2.01B
| $4.87M | 0.03% |
356,344
-3,888
| -1% | -$61.9K |
|
|
ETNB
390
DELISTED
89bio
ETNB
| $4.87M | 0.03% |
+319,498
| New | +$4.17M |
|
391
California Resources
CRC
$4.63B
| $4.83M | 0.03% |
125,396
-10,581
| -8% | -$438K |
|
392
Altria Group
MO
$114B
| $4.82M | 0.03% |
107,985
+7,800
| +8% | +$359K |
|
393
Cboe Global Markets
CBOE
$31.2B
| $4.8M | 0.03% |
35,752
-5,084
| -12% | -$638K |
|
|
CTIC
394
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
| $4.77M | 0.03% |
1,136,381
-334,976
| -23% | -$1.74M |
|
395
Agios Pharmaceuticals
AGIO
$1.82B
| $4.74M | 0.03% |
206,145
-5,512
| -3% | -$146K |
|
396
Everest Group
EG
$14.4B
| $4.72M | 0.03% |
13,197
-1,907
| -13% | -$685K |
|
397
CVR Energy
CVI
$3.31B
| $4.72M | 0.03% |
144,048
-34,282
| -19% | -$1.1M |
|
398
Synchrony
SYF
$25.3B
| $4.67M | 0.03% |
160,691
-23,675
| -13% | -$795K |
|
399
First Solar
FSLR
$25B
| $4.66M | 0.03% |
21,444
+5,187
| +32% | +$947K |
|
|
KYNB
400
Kyntra Bio
KYNB
$27.4M
| $4.58M | 0.03% |
9,828
-553
| -5% | -$293K |
|
Similar funds
CS
AF
SC
JG
Rafferty Asset Management's Q1 2023 Portfolio in Review
As of Q1 2023, Rafferty Asset Management held 1,185 positions worth $14.8B, up 24% from $11.9B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Rafferty Asset Management deployed $1.65B of net new capital in Q1 2023, opening 65 new positions and adding to 729 existing holdings. Its largest new stake was Flagstar Bank National Association: 362,459 shares worth $9.83M.
By sector, the portfolio is most concentrated in Technology at 42% of assets, up from 35% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was iShares Core S&P 500 ETF, an estimated $45M trimmed.
- Rafferty Asset Management's largest Q1 2023 buy was Flagstar Bank National Association: 362,459 shares worth $9.83M.
- Rafferty Asset Management added most to iShares 20+ Year Treasury Bond ETF in Q1 2023, an estimated $323M increase.
- Rafferty Asset Management's biggest Q1 2023 reduction was iShares Core S&P 500 ETF, cutting an estimated $45M.
- Rafferty Asset Management fully exited SVB Financial Group in Q1 2023, selling an estimated $7.88M.
- Rafferty Asset Management's ten largest holdings make up 32% of its $14.8B portfolio in Q1 2023.
- Rafferty Asset Management opened 65 new positions and closed 45 in Q1 2023.
- Rafferty Asset Management's portfolio value rose 24% quarter-over-quarter to $14.8B.
Based on Rafferty Asset Management's 13F filing for Q1 2023, filed 11 May 2023.